Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023:2673:123-130.
doi: 10.1007/978-1-0716-3239-0_8.

Manufacture of Mesoporous Silicon Microparticles (MSMPs) as Adjuvants for Vaccine Delivery

Ana López-Gomez  1   2 , Irene Real-Arévalo  1 , Raúl Martín-Palma  3 , Eduardo Martínez-Naves  2 , Manuel Gómez Del Moral  4
Affiliations

Manufacture of Mesoporous Silicon Microparticles (MSMPs) as Adjuvants for Vaccine Delivery

Ana López-Gomez et al. Methods Mol Biol. 2023.

Abstract

The advent of computational approaches has accelerated the identification of vaccine candidates like epitope peptides. However, epitope peptides are usually very poorly immunogenic and adequate platforms are required with adjuvant capacity to verity immunogenicity and antigenicity of vaccine subunits in vivo. Silicon microparticles are being developed as potential new adjuvants for vaccine delivery due to their physicochemical properties. This chapter explains the methodology to fabricate and functionalize mesoporous silicon microparticles (MSMPs) which can be loaded with antigens of different nature, such as viral peptides, proteins, or carbohydrates, and this strategy is particularly suitable for delivery of epitopes identified by computer.

Keywords: Adjuvant; Carbohydrates; Functionalization; Mesoporous silicon microparticles; Peptides; Vaccine.

PubMed Disclaimer

References

    1. Joshi D, Chbib C, Uddin MN, D’Souza MJ (2021) Evaluation of microparticulate (S)-4,5-dihydroxy-2,3-pentanedione (DPD) as a potential vaccine adjuvant. AAPS J 23:84. https://doi.org/10.1208/s12248-021-00617-6 - DOI - PubMed
    1. Zhang L, Yang W, Hu C et al (2018) Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination. Int J Nanomedicine 13:2973 - DOI - PubMed - PMC
    1. O’Hagan DT, Lodaya RN, Lofano G (2020) The continued advance of vaccine adjuvants – “we can work it out”. Semin Immunol 50:101426 - DOI - PubMed
    1. Navarro-Tovar G, Rocha-García D, Wong-Arce A et al (2018) Mesoporous silicon particles favor the induction of long-lived humoral responses in mice to a peptide-based vaccine. Materials (Basel) 11:1083. https://doi.org/10.3390/ma11071083 - DOI - PubMed
    1. Jiménez-Periáñez A, Abos Gracia B, López Relaño J et al (2013) Mesoporous silicon microparticles enhance MHC class I cross-antigen presentation by human dendritic cells. Clin Dev Immunol 2013:362163. https://doi.org/10.1155/2013/362163 - DOI - PubMed - PMC

Publication types

LinkOut - more resources